Hereditary blood coagulation disorders: Management and dental treatment

Journal of Dental Research

Volumn 84, Issue 11, 2005, Pages 978-985

  Gomez Moreno G ^a   Cutando Soriano, A ^a   Arana, C ^a   Scully, C ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dental treatment; Hereditary coagulation disorders

Indexed keywords

FIBRINOGEN;

BLOOD; BLOOD CLOTTING DISORDER; CLASSIFICATION; DENTAL CARE; GENETICS; HEMOSTASIS; HUMAN; PHYSIOLOGY; REVIEW; THROMBOSIS;

BLOOD COAGULATION DISORDERS, INHERITED; COAGULATION PROTEIN DISORDERS; DENTAL CARE FOR CHRONICALLY ILL; FIBRINOGEN; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 33644660232     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508401102     Document Type: Review

References (71)

1. Alcalay M, Deplas A (2002). Rheumatological management of patients with hemophilia. Part 1: joint manifestations. Joint Bone Spine 69:442-449.
2. Awasthy N, Aggarwal KC, Gupta H, Saluja S (2004). Congenital hypofibrinogenemia. Indian Pediatr 41:185-187.
3. Badurowa A, Galazka Z, Sciborski R (1983). Oral surgery in a patient with congenital factor V deficiency. Wiad Lek 36:1797-1800.
4. Bayry J, Lacroix-Desmazes S, Pashov A, Stahl D, Hoebeke J, Kazatchkine MD, et al. (2003). Autoantibodies to factor VIII with catalytic activity. Autoimmun Rev 2:30-35.
5. Blanchard N, Jeanjean P, Lepointe F, Dieval J, Ossart M (1996). Factor XI deficiency, a new way of substitution: human purified concentrates. Ann Fr Anesth Reanim 15:1207-1210.
6. Brenner B (2000). Hereditary deficiency of vitamin K-dependent coagulation factors. Thromb Haemost 84:935-936.
7. Brewer AK, Roebuck EM, Donachie M, Hazard A, Gordon K, Fung D, et al. (2003). The dental management of adult patients with haemophilia and other congenital bleeding disorders. Haemophilia 9:673-677.
8. Cattaneo M (1997). Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders. Eur J Anaesthesiol Suppl 14:10-14.
9. Cillo J, Pulsipher A, Rutherford CJ, Ellis E 3rd (2001). Third molar extractions in a patient with congenital afibrinogenemia: a case report. J Oral Maxillofac Surg 59:935-936.
10. Crean SJ, Sivarajasingam V, Muhammed J, Sharma V, Fardy M (2000). Thrombophilia and dental surgery: a report of dental extraction in a patient with protein S deficiency. Dent Update 27:302-305.
11. Cutando A, Gil JA (1999). The dental patient with hemostatic disorders. A review of hemostasia physiopathology for dental professionals. Med Oral 4:485-493.
12. Dahlback B (2003). The discovery of activated protein C resistance. J Thromb Haemost 1:3-9.
13. Daly HM, Haddon ME (1988). Clinical experience with a Pasteurised human plasma concentrate in factor XIII deficiency. Thromb Haemost 59:171-174.
14. Deering SH, Landy HJ, Tchabo N, Kessler C (2003). Hypodysfibrinogenemia during pregnancy, labor, and delivery. Obstet Gynecol 101:1092-1094.
15. del Rey López C, Alonso Chico A (2002). Antithrombin III deficiency and regional anesthesia. Rev Esp Anestesiol Reanim 49:117-118.
16. Deloughery TG (1999). Hemostasis and thrombosis. Georgetown, TX: Landes Publishing.
17. Di Paola J, Nugent D, Young G (2001). Current therapy for rare factor deficiencies. Haemophilia 7(Suppl 1):16-22.
18. Diethorn ML, Weld LM (1989). Physiologic mechanisms of hemostasis and fibrinolysis. J Cardiovasc Nurs 4:1-10.
19. Divanon F, Hecquard C, Borel-Derlon A (2002). Experience with use of recombinant activated factor VII. J Clin Pharm Ther 27:133-138.
20. Djulbegovic B, Marasa M, Pesto A, Kushner GM, Hadley T, Joseph G, et al. (1996). Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B. Am J Hematol 51:168-170.
21. Egbring R, Kroniger A, Seitz R (1996). Factor XIII deficiency: pathogenic mechanisms and clinical significance. Semin Thromb Hemost 22:419-425.
22. Eskandari N, Feldman N, Greenspan JS (2002). Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol 99:935-937.
23. Favier R, Aoki N, de Moerloose P (2001). Congenital alpha(2)-plasmin inhibitor deficiencies: a review. Br J Haematol 114:4-10.
24. Franchini M, Capra F, Tagliaferri A, Rossetti G, De Gironcoli M, Rocca P, et al. (2002). Update on chronic hepatitis C in hemophiliacs. Haematologica 87:542-549.
25. François P, Verstraeten L, Dinant JP (1989). The physiology of hemostasis: plasma and tissue factors in coagulation and fibrinolysis. J Pharm Belg 44:308-314.
26. Gatti L, Carnelli V, Rusconi R, Moia M (2003). Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate. J Thromb Haemost 1:387-388.
27. Giangrande PL (2003). Treatment of patients with haemophilia and inhibitory antibodies. Indian J Pediatr 70:655-659.
28. Girolami A, Scarano L, Saggiorato G, Girolami B, Bertomoro A, Marchiori A (1998). Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis 9:557-569.
29. Goraya JS (2001). Congenital deficiency of vitamin K-dependent coagulation factors-a vitamin-K dependency state? (abstract). Thromb Haemost 86:932.
30. Harper K, Friedland ML (1992). Hageman factor deficiency presentation and implications for management. Conn Med 56:469-471.
31. Harrington B (2000). Primary dental care of patients with haemophilia. Haemophilia 6(Suppl 1):7-12.
32. Kasper CK (2000). Hereditary plasma clotting factor disorders and their management. Haemophilia 6(Suppl 1):13-27.
33. Kehrel BE (2003). Blood platelets: biochemistry and physiology. Hamostaseologie 23:149-158.
34. Knight RD, Barr CF, Alving BM (1985). Replacement therapy for congenital Factor X deficiency. Transfusion 25:78-80.
35. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H (1990). Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 29:235-238.
36. Kouides PA, Kulzer L (2001). Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate. Haemophilia 7:220-223.
37. Larson CE, Chang JL, Bleyaert AL, Bedger R (1980). Anesthetic considerations for the oral surgery patient with hemophilia. J Oral Surg 38:516-519.
38. Lee C, Dusheiko G (2002). The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia 8:322-329.
39. Leissinger CA (1999). Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors. Haemophilia 5(Suppl 3):25-32.
40. Little JW, Falace DA, Miller CS, Rhodus NL (1997). Dental management of the medically compromised patient. 5th ed. St. Louis: CV Mosby Co.
41. Mannucci PM (1998). Treatment of von Willebrand disease. Haemophilia 4:661-664.
42. McDonough RJ, Nelson CL (1989). Clinical implications of factor XII deficiency. Oral Surg Oral Med Oral Pathol 68:264-266.
43. Merchant RH, Agarwal BR, Currimbhoy Z, Pherwani A, Avasthi B (1992). Congenital factor XIII deficiency. Indian Pediatr 29:831-836.
44. Meyer D, Pietu G, Fressinaud E, Girma JP (1991). von Willebrand factor: structure and function. Mayo Clin Proc 66:516-523.
45. Montiel-Manzano G, de la Pena-Diaz A, Majluf-Cruz A (2003). National evaluation of the diagnosis of activated protein C resistance. Rev Invest Clin 55:358-369.
46. Morfini M, Lee M, Messori A (1991). The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. Thromb Haemost 66:384-386.
47. Mousallem M, Spronk HM, Sacy R, Hakime N, Soute BA (2001). Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Thromb Haemost 86:1334-1336.
48. Nakahara M, Koyama T (2003). Congenital plasmin inhibitor deficiencies: basic concepts and clinical applications. Rinsho Ketsueki 44:149-158.
49. Narayanan S, Hamasaki N (1998). Current concepts of coagulation and fibrinolysis. Adv Clin Chem 33:133-168.
50. Neerman-Arbez M (2001). The molecular basis of inherited afibrinogenaemia. Thromb Haemost 86:154-163.
51. Nilsson IM (1987). Coagulation and fibrinolysis. Scand J Gastroenterol Suppl 137:11-18.
52. Norris LA (2003). Blood coagulation. Best Pract Res Clin Obstet Gynaecol 17:369-383.
53. Okamoto T, Minami K (2003). Anesthesia for a child with a congenital antithrombin deficiency (abstract). Can J Anaesth 50:311.
54. Pescatore SL (2001). Clinical management of protein C deficiency. Expert Opin Pharmacother 2:431-439.
55. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaert M, Mercier J (2002). Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:247-250.
56. Rand ML, Leung R, Packham MA (2003). Platelet function assays. Transfus Apheresis Sci 28:307-317.
57. Roosendaal O, Lafeber FP (2003). Blood-induced joint damage in hemophilia. Semin Thromb Hemost 29:37-42.
58. Sallah AS, Angchaisuksiri P, Roberts HR (1996). Use of plasma exchange in hereditary deficiency of factor V and factor VIII. Am J Hematol 52:229-230.
59. Schneppenheim R, Budde U (2004). Classification of von Willebrand disease. Hamostaseologie 24:27-36.
60. Scully C, Cawson RA (2004). Medical problems in dentistry. 5th ed. London: Butterworth-Heinemann.
61. Scully C, Diz Dios P, Giangrande P, Lee C (2002). Oral health care in hemophilia and other bleeding tendencies. World Federation on Hemophilia. Treatment of Hemophilia Monograph Series. No. 27. UK: The Faculty of General Dental Practice.
62. Sindet-Pedersen S, Stenbjerg S, Ingerslev J (1988). Control of gingival hemorrhage in hemophilic patients by inhibition of fibrinolysis with tranexamic acid. J Periodontal Res 23:72-74.
63. Stubbs M, Lloyd J (2001). A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B. Aust Dent J 46:37-40.
64. Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmback K, et al. (1998). Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 95:7597-7602.
65. Takahashi H (1993). Biosynthesis in the vascular endothelial cells, molecular structure and function of von Willebrand factor. Nippon Rinsho 51:1635-1642.
66. Troy GC (1988). An overview of hemostasis. Vet Clin North Am Small Anim Pract 18:5-20.
67. Tuddenham EG, Pemberton S, Cooper DN (1995). Inherited factor VII deficiency: genetics and molecular pathology. Thromb Haemost 74:313-321.
68. Uprichard J, Perry DJ (2002). Factor X deficiency. Blood Rev 16:97-110.
69. Wilde JT (2004). HIV and HCV coinfection in haemophilia. Haemophilia 10:1-8.
70. Yamanaka Y, Takeuchi K, Sugimoto M, Sato A, Nakago S, Maruo T (2003). Dysfibrinogenemia during pregnancy treated successfully with fibrinogen. Acta Obstet Gynecol Scand 82:972-973.
71. Zanon E, Martinelli F, Bacci C, Zerbinati P, Girolami A (2000). Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia 6:533-536.